Because MANF is secreted upon cytokine stimulation and can switch macrophages to M2 phenotype, which is pro-tumorigenic, MANF could potentially serve as an immunoregulator in the tumor microenvironment, and as a drug target. This evidence concerns the gene MANF and neoplasm.